eMedicine Specialties > Urology > Stones

Percutaneous Endourology: Treatment

Author: Michael Grasso, MD, Chairman, Department of Urology, Saint Vincent's Medical Center; Professor and Vice Chairman, Department of Urology, New York Medical College
Coauthor(s): Andrew Ira Fishman, MD, Staff Physician, Department of Urology, Saint Vincent Catholic Medical Center; Keith T Tracy, MD, Staff Physician, Department of Urology, New York Medical College, Westchester Medical Center
Contributor Information and Disclosures

Updated: Feb 15, 2008

Treatment

Preoperative Details

A thorough history should be obtained and a physical examination should be performed prior to any procedure. Special attention should be paid to the following historical factors: anticoagulation, bleeding disorders, contrast medium reactions, malignancy, obesity, spinal cord injury, and history of urinary tract infections. Essential laboratory data include a coagulation profile, complete blood cell count, electrolytes, blood urea nitrogen, creatinine, platelet count, urinalysis, and urine culture. Appropriate antibiotic coverage before and on call during the procedure is useful in preventing intraoperative sepsis.

Simple percutaneous renal access procedures are performed with the patient in the prone position while under a combination of local anesthetic and intravenous sedation. This position may be hazardous to patients with severe cardiopulmonary disease (eg, chronic obstructive pulmonary disease) or those who are morbidly obese. Consultation with a pulmonologist or intensivist may be required. If more than a simple drainage procedure is planned, then a general endotracheal anesthetic should be used to protect the airway from aspiration (ie, vasovagal reaction).

Intraoperative Details

Initial access

The ideal percutaneous nephrostomy tract should avoid surrounding organs and provide straight access to the desired calyx. Nephrostomy placement is usually performed under fluoroscopy or with the assistance of real-time ultrasonography. For percutaneous puncture of the renal collecting system, the patient should be placed on the fluoroscopy table in the prone position. The collecting system is then opacified via 1 of 3 techniques: (1) intravenous pyelography, (2) retrograde pyelography, or, if needed, (3) an antegrade ureteropyelography (ie, a 2-stick technique where a small needle is passed first and then a larger needle used for guidewire access.).

A standard lower-pole puncture site is along the posterior axillary line midway between the 12th rib and the iliac crest in the lumbar triangle (Petit triangle). Posterior calices, which project more medially than anterior calices, are preferred. Even though lower-pole access is often useful and may be adequate for drainage, upper-pole access is preferred for ureteral procedures. It is commonly performed above the 12th rib with a low rate of pneumothorax (<3%). The first maneuver is positioning the access needle (18- to 21-gauge) over the desired calyx with posteroanterior fluoroscopy. The fluoroscope's image intensifier is then rotated 30° toward the operating surgeon so that the axis of the posterior calyx is parallel to the fluoroscopic beam. With the shaft of the access needle also in line with the oblique fluoroscopic beam, the tip of the needle is adjusted so it remains on the selected calyx. The needle is then advanced into the posterior calyx.

Direct percutaneous access to the renal pelvis should be avoided to prevent hilar injury. Successful puncture is determined by urine dripping from the sheath after the needle's stylet has been removed. Contrast is then injected through the sheath to opacify the collecting system. A guidewire is then passed through the sheath and coiled in the collecting system. Narrow dilators and subsequently a small nephrostomy tube (6-12F) may then be placed over the guidewire if only simple renal drainage is desired. If a more invasive procedure is planned, dilation with either serial or balloon dilators may be performed to obtain a tract 24-30F in diameter.

Endoscopic intrarenal instrumentation

Nephroscopes are instruments that are inserted percutaneously through a nephrostomy tract. Standard rigid instruments are 19.5-26F in diameter and have rod lenses or fiberoptic imaging with offset eyepieces. Endoscopic lithotripsy is performed by applying a lithotrite through the central working channel. Available instruments include mechanical graspers and various lithotrites (eg, holmium laser, electrohydraulic, hollow-core ultrasonic or lithotriptors) and are complementary to the endoscope as long as they pass through the central channel. Actively deflectable, flexible nephroscopes are also used percutaneously through nephrostomy tracts. They are used to access calculi in calyces that cannot be reached by the rigid instruments and frequently can be deflected into most of the intrarenal collecting system.

Percutaneous treatment of renal stones

In the era of extracorporeal shockwave lithotripsy (ESWL), the indications for percutaneous treatment include (1) urinary obstruction not caused by the stone itself (eg, calyceal diverticulum, UPJ obstruction), (2) large-volume stones that are larger than 2.5 cm (eg, staghorn calculi), (3) stones that are not amenable to ESWL or ureteroscopic treatment (eg, anomalies of the kidney, pelvic kidney, obesity), (4) infectious stone burdens (eg, staghorn calculi), and (5) lower-pole calculi that are deemed inappropriate for ESWL.

When performing a PCNL, smaller mobile stones are removed via graspers, forceps, or flexible/rigid (Perc NCircle) wire baskets. Large dense stones are fragmented using ultrasonic, electrohydraulic, laser, or pneumatic energy. Ultrasonic techniques are preferred because they allow for stone fragmentation with simultaneous in-line suction through a hollow cylindrical probe that continuously removes sand and small fragments. However, ultrasonic lithotripsy can be performed only through a rigid endoscope because any deflection of the probe dramatically decreases the power of this lithotrite. Laser lithotriptors such as the holmium:yttrium-aluminum-garnet laser are particularly powerful and also may be used with flexible endoscopes that can access more of the collecting system but without simultaneous suction to clear debris.

The irrigation used during all percutaneous endoscopic treatments should be sterile warm isotonic sodium chloride solution. Irrigant may be absorbed during treatment via small veins. If significant fluid absorption is suspected, then diuretics (eg, mannitol, furosemide [Lasix]) should be administered intraoperatively.

Following completion of percutaneous endoscopic treatment, a nephrostomy tube should be placed through the tract. The tube type selected depends on the need for future interventions. If repeat procedures are planned, then a reentry Malecot may be used. Other drainage tubes include Foley catheters and regular Malecot drainage catheters.

Success rates have been reported to be as high as 98-99% with PCNL. However, as the size of the stone burden increases, the stone-free rate with a single session drops. Repeat procedures or multiple nephrostomy access tracts may be required for large stone burdens. Repeat or staged surgery often is performed 36-48 hours following the initial procedure, after any bleeding has subsided and endoscopic visibility has improved.

Postoperative Details

Following percutaneous endoscopic procedures involving a significant amount of manipulation of the collecting system (eg, laser lithotripsy, endopyelotomy), urinary drainage is ensured with a nephrostomy drainage catheter and, on occasion, an additional internal ureteral stent. The catheters should be large enough to provide adequate drainage of the kidney and should be chosen relative to the size of the percutaneous access tract used for the surgical intervention. Venous sinus or access tract bleeding can be minimized with the tamponading nature of a large-caliber nephrostomy tube. Simple Foley drainage catheters may be left as a nephrostomy postoperatively, especially if no further endoscopic treatments are required. If staged endoscopic procedures are anticipated and a mature straight nephrostomy tract is required, then a reentry Malecot that combines a nephrostomy with a short ureteral stent is often used.

Postoperatively, patients should be monitored for bleeding, especially in the recovery room. If significant parenchymal bleeding occurred intraoperatively, the hematocrit should be checked and the patient should be appropriately resuscitated. Renal parenchymal bleeding can often be controlled postoperatively by clamping the nephrostomy tube for a short period in the recovery room. The simultaneous administration of diuretics (eg, mannitol, Lasix) and intravenous fluid increases the intraluminal collecting system pressure. If the bleeding is venous in origin, this maneuver stops it once the intrarenal pressure exceeds central venous pressure. Later, urine begins to drain from the nephrostomy as urokinase begins to slowly act on the intrarenal clot. Vigorous attempts at catheter irrigation in the immediate postoperative period only lead to blood loss and should be avoided, if possible.

Chest radiography should be part of the routine postoperative management due to the risk of a pleural tear or perforation when supracostal percutaneous access is obtained. If a pneumothorax or hydrothorax is present, pleurocentesis or placement of a small-diameter thoracostomy tube may be required.

Prophylactic antibiotics routinely are continued postoperatively until all tubes are removed and all puncture sites are healed.

Follow-up

Follow-up imaging and nephrostography are performed routinely after most therapeutic maneuvers, prior to nephrostomy removal. Antegrade studies allow assessment of most treatment outcomes. For example, the presence and location of residual stone material may be assessed, and the patency of the entire collecting system also may be assessed. Mild extravasation may be present at the nephrostomy site and along the tract, but other sites of extravasation secondary to perforations in the collecting system should be allowed to heal with catheter drainage prior to nephrostomy tube removal.

For excellent patient education resources, visit eMedicine's Kidneys and Urinary System Center. Also, see eMedicine's patient education article Kidney Stones.

Complications

Complications associated with percutaneous nephrostomy tube placement alone are uncommon and are usually minor in nature. When more extensive endoscopic maneuvers are used through a nephrostomy tract, the associated complications are more common and severe. The potential complications include the following:

  • Acute bleeding requiring transfusion (<5%): Bleeding may result from traumatized renal parenchyma or injury to a perinephric vessel. Intraoperative hemorrhage is best managed by immediate tamponade. Large nephrostomy tube placement is invariably effective. In rare cases, angiography with embolization or open surgery is needed (<0.1%). Delayed bleeding after nephrostomy removal is uncommon (0.5%).
  • Perforation of the collecting system (20-30%): This common finding, which often occurs with tract dilation, is managed by nephrostomy drainage. Within 24-48 hours, the urothelium seals, given that the collecting system is adequately drained.
  • Pleurotomy/pneumothorax (<5%): Usually associated with a supracostal approach, a pleural injury usually results in a hydrothorax and, infrequently, pneumothorax. Generally, it resolves with simple thoracentesis, but rarely, it may require chest-tube placement and drainage for 48 hours. Chest radiography is recommended following all percutaneous procedures in the recovery room.
  • Sepsis (<1%): Higher rates are noted in those with an infected stone burden. Parenteral antibiotics and nephrostomy drainage are required. Usually, a penicillin-derivative antibiotic and an aminoglycoside are used in combination for initial broad-spectrum coverage.
  • Adjacent organ injury (<1%): Injury may occur to the liver, spleen, duodenum, colon, and adjacent structures. Colonic injury is the most common of these and occurs when the nephrostomy is passed through a redundant portion of the colon before entering the kidney. In cases of colonic injury, management includes repositioning the nephrostomy catheter back until it is in the colon (ie, colostomy tube) and placing an external retrograde ureteral catheter to drain the renal pelvis. Generally, colostomy is indicated only for clinical peritonitis.
  • Contrast reactions (<0.2%): If a problem is anticipated, preoperative steroids (eg, prednisone) should be administered. Should a reaction develop, treatment includes termination of the examination, antihistamines, steroids, H1 and H2 blockers, plus epinephrine, if needed.
  • Acute loss of the nephrostomy tract: This can usually be avoided with the use of a safety wire. If it occurs, the tract may be probed with a guidewire either in an antegrade or in a retrograde fashion; however, a repeat puncture may be required.
  • Leakage from around a nephrostomy tube: Generally, this indicates some type of blockage. This may be caused by a blood clot, a piece of sloughed tissue, or compression of the tube by the flank musculature. Tube compression is more likely with a nephrostomy tube that is too narrow or too soft. Irrigation of the tube usually does not provide a permanent solution; therefore, replacement with a stiffer and/or larger tube is recommended and usually solves the problem.

More on Percutaneous Endourology

Overview: Percutaneous Endourology
Workup: Percutaneous Endourology
Treatment: Percutaneous Endourology
Follow-up: Percutaneous Endourology
Multimedia: Percutaneous Endourology
References
Further Reading

References

  1. Goodwin WE, Casey WC, Woolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis. J Am Med Assoc. Mar 12 1955;157(11):891-4. [Medline].

  2. Fernström I, Johansson B. Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol. 1976;10(3):257-9. [Medline].

  3. Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr, et al. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol. Jun 2005;173(6):1991-2000. [Medline].

  4. Gill IS, Desai MM, Kaouk JH, Wani K, Desai MR. Percutaneous endopyeloplasty: description of new technique. J Urol. Nov 2002;168(5):2097-102. [Medline].

  5. Desai MM, Desai MR, Gill IS. Endopyeloplasty versus endopyelotomy versus laparoscopic pyeloplasty for primary ureteropelvic junction obstruction. Urology. Jul 2004;64(1):16-21; discussion 21. [Medline].

  6. Jackman SV, Hedican SP, Docimo SG, et al. Miniaturized access for pediatric percutaneous nephrolithotomy. J Endourol. 1997;11:S133.

  7. Feng MI, Tamaddon K, Mikhail A, Kaptein JS, Bellman GC. Prospective randomized study of various techniques of percutaneous nephrolithotomy. Urology. Sep 2001;58(3):345-50. [Medline].

  8. Deane LA, Clayman RV. Advances in percutaneous nephrostolithotomy. Urol Clin North Am. Aug 2007;34(3):383-95. [Medline].

  9. Mikhail AA, Kaptein JS, Bellman GC. Use of fibrin glue in percutaneous nephrolithotomy. Urology. May 2003;61(5):910-4; discussion 914. [Medline].

  10. Alken P, Hutschenreiter G, Günther R, Marberger M. Percutaneous stone manipulation. J Urol. Apr 1981;125(4):463-6. [Medline].

  11. Blandy JP, Singh M. The case for a more aggressive approach to staghorn stones. J Urol. May 1976;115(5):505-6. [Medline].

  12. Bloom DA, Morgan RJ, Scardino PL. Thomas Hillier and percutaneous nephrostomy. Urology. Apr 1989;33(4):346-50. [Medline].

  13. Buchholz NP. Three-dimensional CT scan stone reconstruction for the planning of percutaneous surgery in a morbidly obese patient. Urol Int. 2000;65(1):46-8. [Medline].

  14. Wein A, Kavoussi L, Novick A, Partin A, Peters C, eds. Campbell-Walsh Urology. Vol 2. 9th ed. Philadelphia, PA: WB Saunders; 2007:1526-63.

  15. Clayman RV, Castaneda-Zuniga WR. Rigid and flexible nephroscopy. In: Techniques in Endourology: A Guide to the Percutaneous Removal of Renal and Ureteral Calculi. Chicago, Ill: Yearbook Medical Publishers; 1984:153.

  16. Clayman RV, Kavoussi LR. Endosurgical Techniques for Noncalculous Disease. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, eds. Campbell's Urology. 6th ed. Philadelphia, Pa: WB Saunders; 1992:2231.

  17. Coleman CC, Kimura Y, Reddy P. Complications of nephrostolithotomy. Sem Intervent Radiol. 1984;1:24.

  18. Grasso M, Lang G, Loisides P, Bagley D, Taylor F. Endoscopic management of the symptomatic caliceal diverticular calculus. J Urol. Jun 1995;153(6):1878-81. [Medline].

  19. Grasso M, Loisides P, Beaghler M, Bagley D. The case for primary endoscopic management of upper urinary tract calculi: I. A critical review of 121 extracorporeal shock-wave lithotripsy failures. Urology. Mar 1995;45(3):363-71. [Medline].

  20. Grasso MG, Taylor F. Techniques For Percutaneous Renal Access. In: Sosa RE, Albala DM, Jenkins AD, Perlmutter AP, eds. Textbook of Endourology. ed. Philadelphia, Pa: WB Saunders; 1996:99-114.

  21. Grotas A, Grasso M. Endoluminal sonographic imaging of upper urinary tract: three-dimensional reconstruction. J Endourol. Jun 2001;15(5):485-8. [Medline].

  22. Healy KA, Ogan K. Pathophysiology and management of infectious staghorn calculi. Urol Clin North Am. Aug 2007;34(3):363-74. [Medline].

  23. Jackman SV, Docimo SG, Cadeddu JA, Bishoff JT, Kavoussi LR, Jarrett TW. The "mini-perc" technique: a less invasive alternative to percutaneous nephrolithotomy. World J Urol. 1998;16(6):371-4. [Medline].

  24. Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol. Aug 2003;47(2):155-69. [Medline].

  25. Knudsen BE, Cook AJ, Watterson JD, Beiko DT, Nott L, Razvi H, et al. Percutaneous antegrade endopyelotomy: long-term results from one institution. Urology. Feb 2004;63(2):230-4. [Medline].

  26. Lam HS, Lingeman JE, Mosbaugh PG, Steele RE, Knapp PM, Scott JW, et al. Evolution of the technique of combination therapy for staghorn calculi: a decreasing role for extracorporeal shock wave lithotripsy. J Urol. Sep 1992;148(3 Pt 2):1058-62. [Medline].

  27. Leder RA, Nelson RC. Three-dimensional CT of the genitourinary tract. J Endourol. Feb 2001;15(1):37-46. [Medline].

  28. LeRoy AJ, Williams HJ Jr, Bender CE, Segura JW, Patterson DE, Benson RC. Colon perforation following percutaneous nephrostomy and renal calculus removal. Radiology. Apr 1985;155(1):83-5. [Medline].

  29. Limb J, Bellman GC. Tubeless percutaneous renal surgery: review of first 112 patients. Urology. Apr 2002;59(4):527-31; discussion 531. [Medline].

  30. Liu JB, Miller LS, Bagley DH, Goldberg BB. Endoluminal sonography of the genitourinary and gastrointestinal tracts. J Ultrasound Med. Mar 2002;21(3):323-37. [Medline].

  31. Murphy DP, Gill IS, Streem SB. Evolving management of upper-tract transitional-cell carcinoma at a tertiary-care center. J Endourol. Sep 2002;16(7):483-7. [Medline].

  32. Nagele U, Schilling D, Anastasiadis AG, Corvin S, Seibold J, Kuczyk M, et al. Closing the tract of mini-percutaneous nephrolithotomy with gelatine matrix hemostatic sealant can replace nephrostomy tube placement. Urology. Sep 2006;68(3):489-93; discussion 493-4. [Medline].

  33. Noller MW, Baughman SM, Morey AF, Auge BK. Fibrin sealant enables tubeless percutaneous stone surgery. J Urol. Jul 2004;172(1):166-9. [Medline].

  34. Picus D, Weyman PJ, Clayman RV, McClennan BL. Intercostal-space nephrostomy for percutaneous stone removal. AJR Am J Roentgenol. Aug 1986;147(2):393-7. [Medline].

  35. Rapp DE, Gerber GS. Management of caliceal diverticula. J Endourol. Nov 2004;18(9):805-10. [Medline].

  36. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol. Jun 1994;151(6):1648-51. [Medline].

  37. Shah HN, Kausik V, Hedge S, Shah JN, Bansal MB. Initial experience with hemostatic fibrin glue as adjuvant during tubeless percutaneous nephrolithotomy. J Endourol. Mar 2006;20(3):194-8. [Medline].

  38. Smith AD. Management of iatrogenic ureteral strictures after urological procedures. J Urol. Dec 1988;140(6):1372-4. [Medline].

  39. Sung YM, Choo SW, Jeon SS, Shin SW, Park KB, Do YS. The "mini-perc" technique of percutaneous nephrolithotomy with a 14-Fr peel-away sheath: 3-year results in 72 patients. Korean J Radiol. Jan-Mar 2006;7(1):50-6. [Medline].

  40. Tan BJ, Smith AD. Ureteropelvic junction obstruction repair: when, how, what?. Curr Opin Urol. Mar 2004;14(2):55-9. [Medline].

  41. Uribe CA, Eichel L, Khonsari S, Finley DS, Basillote J, Park HK, et al. What happens to hemostatic agents in contact with urine? An in vitro study. J Endourol. Apr 2005;19(3):312-7. [Medline].

  42. Watterson JD, Soon S, Jana K. Access related complications during percutaneous nephrolithotomy: urology versus radiology at a single academic institution. J Urol. Jul 2006;176(1):142-5. [Medline].

  43. Whitaker RH. An evaluation of 170 diagnostic pressure flow studies of the upper urinary tract. J Urol. May 1979;121(5):602-4. [Medline].

  44. Winfield HW, Clayman RV. Complications of percutaneous removal of renal and ureteral calculi. Part I. World Urology Update Series. 1985;2:Lesson 37.

Further Reading

For additional information, see Medscape’s Stone Disease Resource Center.

Keywords

percutaneous endourology, PCNL, PERC, kidney, upper urinary tract, catheterization, catheter, drainage, endoscopic, endoscope, kidney stones, stones, large stone burdens, strictures, ureteropelvic junction obstruction, UPJ obstruction, upper-tract lesion, upper tract lesion, antegrade pyelography, pressure/perfusion study, Whitaker test, nephrostomy catheter drainage, antegrade ureteral stenting, ureteral stricture, percutaneous endopyelotomy, percutaneous nephrostolithotomy, percutaneous nephrolithotomy, perfusion chemolysis, renal stone, endoscopic resection, urothelial tumor, laparoscopic pyeloplasty, percutaneous endopyeloplasty, mini-perc, tubeless PCNL, tubeless percutaneous nephrolithotomy, tubeless percutaneous nephrostolithotomy, percutaneous access, staghorn calculus

Contributor Information and Disclosures

Author

Michael Grasso, MD, Chairman, Department of Urology, Saint Vincent's Medical Center; Professor and Vice Chairman, Department of Urology, New York Medical College
Michael Grasso, MD is a member of the following medical societies: American Medical Association, American Urological Association, California Medical Association, and Endourological Society
Disclosure: Karl Storz Endoscopy Consulting fee Consulting; Boston Scientific Consulting fee Consulting; Cook Urologic Consulting fee Consulting

Coauthor(s)

Andrew Ira Fishman, MD, Staff Physician, Department of Urology, Saint Vincent Catholic Medical Center
Andrew Ira Fishman, MD is a member of the following medical societies: American Medical Association and American Urological Association
Disclosure: Nothing to disclose.

Keith T Tracy, MD, Staff Physician, Department of Urology, New York Medical College, Westchester Medical Center
Keith T Tracy, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, and American Urological Association
Disclosure: Nothing to disclose.

Medical Editor

Allen Donald Seftel, MD, Professor, Department of Urology, Case School of Medicine
Allen Donald Seftel, MD is a member of the following medical societies: Ohio State Medical Association
Disclosure: lilly Consulting fee Consulting; sanofi-aventis Consulting fee Consulting; auxilium Consulting fee Consulting; solvay Consulting fee Consulting; plethora Grant/research funds clinical trial; indevus Consulting fee Consulting; nature publishing  journal editor

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Shlomo Raz, MD, Professor, Department of Surgery, Division of Urology, University of California at Los Angeles School of Medicine
Shlomo Raz, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, and California Medical Association
Disclosure: Nothing to disclose.

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Gyrus-ACMI Honoraria Speaking and teaching

Chief Editor

Bradley Fields Schwartz, DO, FACS, Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.